GTC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE ADVANCED SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Genes to Cells (2009) 14, 69-77. doi:10.1111/j.1365-2443.2008.01252.x
© 2009 Blackwell Publishing or its licensors

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kaneda, R.
Right arrow Articles by Mano, H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Kaneda, R.
Right arrow Articles by Mano, H.

Genome-wide histone methylation profile for heart failure

Ruri Kaneda1,2, Shuji Takada1, Yoshihiro Yamashita1, Young Lim Choi1, Mutsuko Nonaka-Sarukawa2, Manabu Soda1, Yoshio Misawa3, Tadashi Isomura4, Kazuyuki Shimada2 and Hiroyuki Mano1,5,*

Divisions of
1 Functional Genomics, Jichi Medical University, Tochigi 329-0498, Japan
2 Cardiovascular Medicine, Jichi Medical University, Tochigi 329-0498, Japan
3 Cardiovascular Surgery, Jichi Medical University, Tochigi 329-0498, Japan
4 Hayama Heart Center, Kanagawa 240-0116, Japan
5 CREST, Japan Science and Technology Agency, Saitama 332-0012, Japan

Epigenetic alterations are implicated in the development of cardiac hypertrophy and heart failure, but little is known of which epigenetic changes in which regions of the genome play such a role. We now show that trimethylation of histone H3 on lysine-4 (K4TM) or lysine-9 (K9TM) is markedly affected in cardiomyocytes in association with the development of heart failure in a rat disease model. High-throughput pyrosequencing performed with ChIP products for K4TM or K9TM prepared from human left ventricular tissue with retained or damaged function also revealed that protein-coding genes located in the vicinity of K4TM marks differ between functional and disabled myocytes, yet both sets of genes encode proteins that function in the same signal transduction pathways for cardiac function, indicative of differential K4TM marking during the development of heart failure. However, K9TM mark-profile was less dependent on the disease status compared to that of K4TM. Our data collectively reveal global epigenetic changes in cardiac myocytes associated with heart failure.


Communicated by: Kohei Miyazono

* Correspondence: hmano{at}jichi.ac.jp




This article has been cited by other articles:


Home page
Circ Cardiovasc GenetHome page
A. J. Marian
Nature's Genetic Gradients and the Clinical Phenotype
Circ Cardiovasc Genet, December 1, 2009; 2(6): 537 - 539.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K. B. Margulies, D. P. Bednarik, and D. L. Dries
Genomics, transcriptional profiling, and heart failure.
J. Am. Coll. Cardiol., May 12, 2009; 53(19): 1752 - 1759.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE ADVANCED SEARCH TABLE OF CONTENTS
Copyright © 2009 by Wiley-Blackwell Publishing.